Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "poison pill."
12 result(s) displayed (1 - 12 of 24)
Two hedge funds claim the REIT's executives are only interested in preserving the flow of management fees, not in maximizing the property portfolio to benefit investors. Continue reading
Posted on March 19, 2013 4:02 PM
Leucadia National plans to tender its 15.9% stake to the hostile $5.2 billion offer. Continue reading
Posted on January 11, 2013 8:58 AM
The 8.2% shareholder follows a Platinum Equity affiliate in criticizing the plastic maker's performance. Continue reading
Posted on November 14, 2012 2:24 PM
The expected move sets up a second proxy battle with the activist investor. Continue reading
Posted on October 26, 2012 10:47 AM
Kirkland's' Daniel Wolf tells The Deal Pipeline about his unique experience in advising Bristol-Myers Squibb in its $2.5 billion acquisition of Inhibitex. Continue reading
Posted on June 7, 2012 4:00 AM
Kirkland's' Daniel Wolf tells The Deal Pipeline about his unique experience in advising Bristol-Myers Squibb in its $2.5 billion acquisition of Inhibitex. Continue reading
Posted on June 6, 2012 1:06 PM
The struggling women's retailer agrees to a deal at a decreased bid from the private equity firm of $2.75 per share. Continue reading
Posted on June 1, 2012 8:27 AM
The activist investor will be allowed to complete his $2.6 billion tender offer for the oil refiner should a majority of shares support him. Continue reading
Posted on April 19, 2012 11:20 AM
The drug giant's flat first-quarter revenues come just a day after Roche reiterated its calls for negotiations with the board of the gene sequencing specialist. Continue reading
Posted on April 12, 2012 8:45 AM
The plan, to be triggered at a 20% ownership threshold, is aimed against activist shareholder Sardar Biglari Continue reading
Posted on April 10, 2012 4:18 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
